This is a Notice of Intent to award a firm-fixed-price purchase order to Luminex Corp. as the sole responsible source for the Luminex 200 IVD System. This system is required for high-throughput, multiplexed genomic and proteomic biomarker analysis in clinical trials at the National Cancer Institute (NCI). The system's XMAP technology and 21 CFR Part 11 compliance module are critical for data integrity and regulatory standards. This notice is not a request for competitive quotes. Small businesses are invited to submit a capability statement demonstrating their ability to meet the requirements by 11:00 p. m. EDT on May 9, 2026. The government will determine if further competition is warranted based on responses.
The bid notice does not specify a delivery deadline.
The bid notice does not specify payment terms.
The bid notice does not specify warranty information.
The bid notice states that Luminex Corp. is the only known responsible source who can provide the products/services that meet the standards, indicating a sole source award. The bid notice states The bid notice states that Luminex Corp. is the only known responsible source who can provide the products/services that meet our standards.
The bid notice states that Luminex Corp. is the only known responsible source who can provide the products/services that meet our standards. The bid notice states Luminex corp is the only known responsible source who canprovide the productsservices that meet our standards.
The bid notice does not specify penalties.
The bid notice does not mention a site visit.
The bid notice does not mention sample submission.
The bid notice does not specify a challenge deadline.
The bid notice does not specify an estimated value.